ASML’s, Billion

ASML’s €600 Billion Valuation Hinges on a Single Data Point: Q2 Order Intake

01.07.2026 - 07:44:39 | boerse-global.de

ASML stock surges 76% YTD ahead of July 15 earnings. EUV monopoly faces geopolitical risk from MATCH Act. Key revenue, margin, and order book data.

ASML Q2 2026 Earnings Preview: EUV Monopoly at Record Highs Amid $2T Chip Surge
ASML’s - ASML’s €600 Billion Valuation Hinges on a Single Data Point: Q2 Order Intake 01.07.2026 - Bild: über boerse-global.de

The semiconductor sector enters the second half of 2026 with a dizzying run-up that has added roughly $2 trillion to market capitalisation in the past three months alone. AMD, Intel and Marvell Technology are all flirting with record levels, Taiwan Semiconductor Manufacturing Co. hit a fresh 52-week peak on Wednesday, and ASML — the Dutch lithography monopoly that sits at the very bottleneck of chip production — is about to deliver what may be the most consequential quarterly report of the year. The stakes could hardly be higher. July 15 will reveal whether the 76% year-to-date rally in ASML’s stock is built on a solid foundation of incoming orders or on hope alone.

A Technical Tightrope Walk

ASML closed at €1,737.80, a mere 0.58% below its 52-week high and within striking distance of the €2,000 target recently set by Barclays. Bank of America went even further with a $2,345 price objective, and Aletheia Capital executed a rare flip from sell to buy, citing rising demand for extreme ultraviolet (EUV) machines. The share price has more than doubled since the August 2025 trough of €593.60, a surge that has pushed the 30-day annualised volatility to 56%. The relative strength index sits at 64.3 — elevated but not yet flashing overbought. Investors are pricing in a binary event.

The company’s own guidance, raised in April, calls for full-year 2026 revenue between €36 billion and €40 billion with a gross margin of 51% to 53%. First-quarter numbers already offered a glimpse of the trajectory: revenue of €8.77 billion, a gross margin of 53% and net profit of €2.76 billion. For the full fiscal 2025, sales climbed nearly 16% to €32.67 billion. The bull case rests on the ability to sustain that momentum.

The Monopoly as a Moat

ASML is the sole producer of EUV lithography systems, each priced at roughly $300 million, that use laser-generated plasma to imprint the tiniest circuitry on advanced chips. Chief Executive Christophe Fouquet has stated bluntly that chip demand outstrips supply and that customers are accelerating their capacity plans for 2026 and beyond. Chief Financial Officer Roger Dassen added that the company expects to ship about 60 of its best-selling low-NA EUV systems this year — a 25% increase from 2025 — and is preparing capacity for 80 systems in 2027.

Should investors sell immediately? Or is it worth buying Asml?

The installed-base service business provides a further cushion. In the first quarter alone, maintenance and upgrades contributed €2.5 billion in revenue at above-average margins. As long as the AI infrastructure spending super-cycle continues, ASML’s order book is structurally overbooked, supporting the upper end of the full-year forecast.

A Geopolitical Sword of Damocles

Yet the most immediate threat to the narrative is not cyclical but legislative. A bipartisan group of U.S. lawmakers has introduced the MATCH Act, a bill aimed at curbing Dutch exports of deep ultraviolet (DUV) lithography systems to China. The legislation goes beyond previous restrictions and, if enacted, could jeopardise not only new machine sales but also software updates, spare parts and maintenance services for equipment already installed in China — a lucrative revenue stream that has largely flown under the radar.

China accounted for roughly 20% of ASML’s total revenue in the first quarter, down sharply from 36% of net system sales in the fourth quarter of 2025. The stock shed nearly 8% when details of the bill emerged and earlier export-control rumours surfaced. Analysts estimate that a tougher regulatory environment could shave a low-single-digit percentage off revenue and reduce earnings per share by as much as 10%, though capacity shifts by non-Chinese chipmakers may offset part of the blow. Dutch Trade Minister Sjoerd Sjoerdsma has been lobbying in Washington, meeting both Commerce Secretary Howard Lutnick and members of Congress to push back against further export restrictions. The MATCH Act has not yet passed.

Asml at a turning point? This analysis reveals what investors need to know now.

Orders: The Single Metric That Matters

With the stock trading more than 50% above its 200-day moving average, the room for disappointment is microscopically thin. The single number that will determine the immediate direction on July 15 is net order intake for the second quarter. A reading that fails to support the top end of the €36b–€40b guidance would likely trigger a sharp correction. Conversely, a strong print would validate the re-rating and reinforce ASML’s status as the cornerstone of the AI chip ecosystem.

The company reports before the market opens next Tuesday. Alongside the order book, investors will be parsing every word from management on the trajectory of China exposure and any update on the legislative risk simmering in Washington. For a stock that has already priced in a great deal of good news, the balance between monopoly power and political headwinds has never been more finely poised.

Ad

Asml Stock: New Analysis - 1 July

Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Asml analysis...

en | NL0010273215 | ASML’S | boerse | 69665516 |